- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Naloxone – March 2019
Naloxone: 2.2 mg/actuation nasal spray, 2 x 1 actuation; Nyxoid®
Last updated
5 July 2019